Oncotelic Therapeutics to Present Sapu003 Breast Cancer Treatment Data at 2025 Symposium
Oncotelic Therapeutics will present clinical data on Sapu003, a novel breast cancer treatment designed to improve bioavailability and reduce toxicity, at the 2025 San Antonio Breast Cancer Symposium.
Read the full story

























